MACDOUGALL ANN L. purchased 12.9% of their position (3K shares) of OPIANT PHARMACEUTICALS, INC. on the open market
Open‑market purchase worth $32.8K — a moderate purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 5/16/2022ACC: 0001385508-22-000057
Director
Since Jun 2019
+3K
Net shares
Net buyer
$32.8K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
3K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+3K
Price / share
$10.93
Trade value
$32.78K
% of position
12.9%
5/13/2022
23.18K→26.18K
Total
Net shares
+3K
Net value
$32.78K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/13/2022 | P · Purchase | +3K | $10.93 | $32.78K | 12.9% | 23.18K | 26.18K |
| Total | +3K | $32.78K | ||||||
Derivative Transactions0
No derivative transactions reported